NeoGenomics is trading 8.88% up at $19.50, with the move appearing most consistent with a rebound in a volatile recent trading pattern.
- It closed at $17.91 on August 31, 2026.
- No new company-specific announcement, earnings release, or analyst action dated September 1, 2026 was identified to directly explain the pre-market jump.
- Major U.S. indices were lower; the FDA-approved PTEN IHC companion diagnostic launch was previously reported, not new on September 1.